Literature DB >> 3163347

Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors.

C Koo1, M E Wernette-Hammond, Z Garcia, M J Malloy, R Uauy, C East, D W Bilheimer, R W Mahley, T L Innerarity.   

Abstract

The uptake and degradation of cholesterol-rich remnant lipoproteins, referred to as beta-VLDL, are shown in the present study to be mediated by LDL receptors (apoB,E(LDL) receptors), not by unique beta-VLDL receptors. Human blood monocytes cultured for 5-7 d bound apoB- and/or apoE-containing lipoproteins from different species with affinities equivalent to those demonstrated for the receptors on cultured human fibroblasts. Low density lipoproteins competed effectively and completely with 125I-beta-VLDL for binding to and degradation by monocyte-derived macrophages. Specific polyclonal antibodies to bovine apoB,E(LDL) receptors abolished both LDL and beta-VLDL uptake by normal human monocyte-macrophages. Immunoblots of monocyte-macrophage extracts with these antibodies revealed a single protein in human macrophages with an apparent molecular weight identical to that of the apoB,E(LDL) receptor found on human fibroblasts. Like receptors on cultured human fibroblasts, the apoB,E(LDL) receptors on monocyte-macrophages responsible for 125I-beta-VLDL and 125I-LDL uptake were efficiently down regulated by preincubation of the cells with beta-VLDL or LDL. Finally, monocyte-macrophages from seven homozygous familial hypercholesterolemia subjects were unable to metabolize beta-VLDL or LDL, but demonstrated normal uptake of acetoacetylated LDL. The classic apoB,E(LDL) receptors on human monocyte-macrophages thus mediate the uptake of beta-VLDL by these cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3163347      PMCID: PMC442561          DOI: 10.1172/JCI113460

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Rate and equilibrium constants for binding of apo-E HDLc (a cholesterol-induced lipoprotein) and low density lipoproteins to human fibroblasts: evidence for multiple receptor binding of apo-E HDLc.

Authors:  R E Pitas; T L Innerarity; K S Arnold; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

2.  Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts.

Authors:  K H Weisgraber; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1978-12-25       Impact factor: 5.157

3.  Estimation of hormone receptor affinity by competitive displacement of labeled ligand: effect of concentration of receptor and of labeled ligand.

Authors:  S Jacobs; P Cuatrecasas
Journal:  Biochem Biophys Res Commun       Date:  1975-09-16       Impact factor: 3.575

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

6.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

7.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

Authors:  D W Bilheimer; S Eisenberg; R I Levy
Journal:  Biochim Biophys Acta       Date:  1972-02-21

8.  Canine hyperlipoproteinemia and atherosclerosis. Accumulation of lipid by aortic medial cells in vivo and in vitro.

Authors:  R W Mahley; T L Innerarity; K H Weisgraber; D L Fry
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

9.  Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine beta-very low density lipoproteins.

Authors:  J L Goldstein; Y K Ho; M S Brown; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1980-03-10       Impact factor: 5.157

10.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

Authors:  J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1974-08-25       Impact factor: 5.157

View more
  12 in total

1.  Beta-migrating very-low-density lipoprotein, chylomicron remnants and their receptors.

Authors:  W Liao
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

2.  Vitamin E reduces cholesterol esterification and uptake of acetylated low density lipoprotein in macrophages.

Authors:  H Shige; T Ishikawa; M Suzukawa; M Nishiwaki; T Yamashita; K Nakajima; T Ito; K Higashi; M Ayaori; A Yonemura; P Nestel; H Nakamura
Journal:  Lipids       Date:  1998-12       Impact factor: 1.880

3.  Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.

Authors:  J Fan; Z S Ji; Y Huang; H de Silva; D Sanan; R W Mahley; T L Innerarity; J M Taylor
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

4.  Apolipoprotein E4 in macrophages enhances atherogenesis in a low density lipoprotein receptor-dependent manner.

Authors:  Michael Altenburg; Lance Johnson; Jennifer Wilder; Nobuyo Maeda
Journal:  J Biol Chem       Date:  2007-01-18       Impact factor: 5.157

5.  Lipoprotein-proteoglycan complexes induce continued cholesteryl ester accumulation in foam cells from rabbit atherosclerotic lesions.

Authors:  P Vijayagopal; S R Srinivasan; J H Xu; E R Dalferes; B Radhakrishnamurthy; G S Berenson
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

6.  Human monocyte-derived macrophages bind low-density-lipoprotein-proteoglycan complexes by a receptor different from the low-density-lipoprotein receptor.

Authors:  P Vijayagopal; S R Srinivasan; B Radhakrishnamurthy; G S Berenson
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

7.  Differential low density lipoprotein receptor-dependent formation of eicosanoids in human blood-derived monocytes.

Authors:  P B Salbach; E Specht; E von Hodenberg; J Kossmann; U Janssen-Timmen; W J Schneider; P Hugger; W C King; J A Glomset; A J Habenicht
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  Characterization of the low-density-lipoprotein-receptor-independent interaction of beta-very-low-density lipoprotein with rat and human parenchymal liver cells in vitro.

Authors:  R De Water; J A Kamps; M C Van Dijk; E A Hessels; J Kuiper; J K Kruijt; T J Van Berkel
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

9.  High-fat diet-induced GAIT element-mediated translational silencing of mRNAs encoding inflammatory proteins in macrophage protects against atherosclerosis.

Authors:  Abhijit Basu; Nina Dvorina; William M Baldwin; Barsanjit Mazumder
Journal:  FASEB J       Date:  2020-03-30       Impact factor: 5.191

10.  Phospholipase A2 mediates apolipoprotein-independent uptake of chylomicron remnant-like particles by human macrophages.

Authors:  Mariarosaria Napolitano; Howard S Kruth; Elena Bravo
Journal:  Int J Vasc Med       Date:  2011-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.